Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
TRTourmaline Bio, Inc. logo

Tourmaline Bio, Inc. (TRML)

NASDAQ Global Select · Currency in USD
$47.98 ▲ +0.00 (+0.00%)
At close: Oct 28, 4:00 PM ET. Market closed.

Summary

Previous Close
$47.98
Open
$47.98
Day's Range
$47.98 – $47.98
52 Week Range
$11.56 – $48.27
Volume
783,730
Avg. Volume
925,778
Market Cap
$1.23B
Beta (5Y Monthly)
1.58
PE Ratio (TTM)
--
EPS (TTM)
-$2.89
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
Oct 20, 2023
1y Target Est
$48.50

Profile: Tourmaline Bio, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
74
CEO
Sandeep C. Kulkarni

Tourmaline Bio, Inc. is a clinical-stage biotechnology firm committed to advancing therapies for individuals suffering from debilitating immune disorders. The company's development pipeline focuses on conditions such as Atherosclerotic Cardiovascular Disease (ASCVD) and Thyroid Eye Disease (TED). Established in 2021, this enterprise is headquartered in New York, New York.

Earnings

DateEst.Actual
Nov 6, 2025-$0.96-$0.78Beat
Aug 13, 2025-$0.94-$0.90Beat
May 2, 2025-$0.91-$0.89Beat
Mar 13, 2025-$0.91-$0.86Beat
Nov 7, 2024-$0.84-$0.78Beat
Aug 8, 2024-$0.72-$0.68Beat

Analyst view

Consensus price target
$48.50 ▲ +1.1%
Range $47.50 – $50.00
Rating: Hold
Buy 10% · Hold 90% · Sell 0%

Get free alerts on TRML and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.